CVS:NYE-CVS Health Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 57.53

Change

+1.42 (+2.53)%

Market Cap

USD 78.05B

Volume

7.14M

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-12 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

-5.18 (-0.87%)

USD 553.16B
ELV Elevance Health Inc

+2.66 (+0.48%)

USD 126.07B
CNC Centene Corp

+1.22 (+1.62%)

USD 37.35B
MOH Molina Healthcare Inc

+2.57 (+0.72%)

USD 19.48B
OSCR Oscar Health Inc

+0.31 (+1.43%)

USD 4.11B
NEUE NeueHealth Inc

-0.14 (-2.56%)

USD 0.05B
CI Cigna Corp

+2.13 (+0.58%)

N/A
HUM Humana Inc

-6.33 (-1.97%)

N/A

ETFs Containing CVS

CFCV 3.68 % 0.00 %

N/A

N/A
UVAL:LSE SPDR® MSCI USA Value UCI.. 2.45 % 0.00 %

+0.11 (+0%)

USD 0.13B
USVL:LSE SPDR® MSCI USA Value UCI.. 2.45 % 0.00 %

+0.55 (+0%)

USD 0.13B
ZPRU:F SSgA SPDR ETFs Europe II .. 2.45 % 0.00 %

+0.24 (+0%)

USD 0.13B
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 2.45 % 0.00 %

+0.13 (+0%)

USD 0.13B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.45 % 0.00 %

+0.21 (+0%)

USD 0.13B
CVY Invesco Zacks Multi-Asset.. 1.09 % 0.65 %

+0.17 (+0%)

USD 0.12B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

+0.21 (+0%)

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

+0.02 (+0%)

USD 0.09B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

+0.11 (+0%)

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.05 (+0%)

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.05 (+0%)

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

N/A

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

-0.06 (0%)

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

-0.01 (0%)

USD 0.31B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

+0.14 (+0%)

USD 0.96B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

-0.01 (0%)

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.12 (+0%)

USD 0.05B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.11 (+0%)

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

+0.35 (+0%)

USD 0.62B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

+0.50 (+0%)

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

+0.19 (+0%)

USD 1.00B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

+0.06 (+0%)

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

+0.39 (+0%)

USD 2.71B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

+0.04 (+0%)

USD 2.20B
RTH VanEck Retail ETF 0.00 % 0.35 %

-0.05 (0%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

+0.39 (+0%)

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

+0.04 (+0%)

USD 2.09B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

+0.50 (+0%)

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.51 (+0%)

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
WBIY WBI Power Factor® High D.. 0.00 % 0.70 %

+0.24 (+0%)

USD 0.06B
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

-1.50 (0%)

USD 0.09B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -27.14% 25% F 8% B-
Dividend Return 2.53% 100% F 52% F
Total Return -24.61% 25% F 8% B-
Trailing 12 Months  
Capital Gain -17.76% 25% F 13% F
Dividend Return 3.72% 100% F 54% F
Total Return -14.04% 25% F 13% F
Trailing 5 Years  
Capital Gain -10.19% 17% F 32% F
Dividend Return 17.35% 100% F 62% D
Total Return 7.16% 17% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain 3.33% 25% F 51% F
Dividend Return 6.11% 38% F 52% F
Total Return 2.78% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 26.23% 25% F 40% F
Risk Adjusted Return 23.29% 13% F 42% F
Market Capitalization 78.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector